Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference
06 März 2024 - 2:05PM
Business Wire
Senseonics Holdings, Inc. (NYSE American: SENS), a medical
technology company focused on the development and manufacturing of
long-term, implantable continuous glucose monitoring (CGM) systems
for people with diabetes, today announced plans to participate in
the upcoming Oppenheimer Healthcare MedTech & Services
Conference, being held virtually.
Management is scheduled to participate on Wednesday, March 13,
2024, at 12:00pm ET and will hold one-on-one meetings following.
Interested parties may access a live and recorded webcast of the
presentation on the “Investor Relations” section of the company’s
website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology
company focused on the development and manufacturing of glucose
monitoring products designed to transform lives in the global
diabetes community with differentiated, long-term implantable
glucose management technology. Senseonics’ CGM system Eversense® E3
includes a small sensor inserted completely under the skin that
communicates with a smart transmitter worn over the sensor. The
glucose data are automatically sent every 5 minutes to a mobile app
on the user’s smartphone.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240306655647/en/
Senseonics Investor Contact Philip Taylor Gilmartin Group
415-937-5406 Investors@senseonics.com
Senseonics (AMEX:SENS)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Senseonics (AMEX:SENS)
Historical Stock Chart
Von Nov 2023 bis Nov 2024